Summarized by Masters of Longevity from FDA - Drugs.
FDA approved pirtobrutinib for adults with relapsed CLL or SLL.
Key Takeaways
- Pirtobrutinib was granted accelerated FDA approval for CLL and SLL.
- Approval is for adults with at least two prior therapies including BTK.
- Accelerated status requires confirmatory trials to verify clinical benefit.
